Ryder System Inc. (R)
NYSE: R
· Real-Time Price · USD
146.97
-3.74 (-2.48%)
At close: May 30, 2025, 3:59 PM
146.84
-0.09%
After-hours: May 30, 2025, 05:29 PM EDT
-2.48% (1D)
| Bid | 144.19 |
| Market Cap | 6.08B |
| Revenue (ttm) | 12.7B |
| Net Income (ttm) | 502M |
| EPS (ttm) | 11.29 |
| PE Ratio (ttm) | 13.02 |
| Forward PE | 10.22 |
| Analyst | Buy |
| Ask | 155.11 |
| Volume | 535,572 |
| Avg. Volume (20D) | 400,559 |
| Open | 150.31 |
| Previous Close | 150.71 |
| Day's Range | 146.37 - 150.79 |
| 52-Week Range | 116.58 - 171.78 |
| Beta | 0.93 |
Analyst Forecast
According to 0 analyst ratings, the average rating for R stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
-4.25%
Ryder System shares are trading lower after the co...
Unlock content with
Pro Subscription
10 months ago
+3.02%
Ryder shares are trading higher after the company raised its dividend.
2 weeks ago · accessnewswire.com
Three-Year VenoValve(R) First-in-Human Trial Data Published in the Annals of Vascular SurgeryPromising results from the first-in-human study demonstrated that, at three-years post implantation, VenoValve remained safe and effective--achieving a high rate of patency, restoring deep venous comp...
